CRIS Current Research Information System

POERIO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.068
EU - Europa 815
AS - Asia 397
AF - Africa 74
SA - Sud America 3
Totale 2.357
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.065
GB - Regno Unito 248
SE - Svezia 167
VN - Vietnam 128
CN - Cina 98
IT - Italia 90
DE - Germania 88
JP - Giappone 72
UA - Ucraina 64
IN - India 44
IE - Irlanda 34
TG - Togo 33
FR - Francia 32
RU - Federazione Russa 24
SG - Singapore 23
CI - Costa d'Avorio 20
CH - Svizzera 15
EE - Estonia 14
JO - Giordania 14
ZA - Sudafrica 14
BG - Bulgaria 11
BE - Belgio 10
GR - Grecia 8
IR - Iran 6
FI - Finlandia 5
SC - Seychelles 4
CA - Canada 3
NG - Nigeria 3
NL - Olanda 3
TR - Turchia 3
BD - Bangladesh 2
BR - Brasile 2
KR - Corea 2
PH - Filippine 2
CL - Cile 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
LB - Libano 1
RO - Romania 1
Totale 2.357
Salva come PNG Salva come JPEG
Città #
Southend 216
Chandler 180
Fairfield 108
Ashburn 87
Woodbridge 70
Tokyo 64
Houston 61
Dong Ket 59
Wilmington 59
Seattle 57
Ann Arbor 56
Jacksonville 44
Princeton 39
Cambridge 35
Dublin 34
Lomé 33
Turin 22
Abidjan 20
Falls Church 20
Nanjing 20
Westminster 19
New York 18
Padova 18
Singapore 15
Amman 14
Bern 14
Berlin 11
Sofia 11
Brussels 10
Jinan 9
Saint Petersburg 8
Boardman 7
Jiaxing 7
Milan 7
Nanchang 7
San Diego 7
Taizhou 7
Beijing 6
Shenyang 6
Bremen 5
Des Moines 5
Hebei 5
Helsinki 5
Medford 5
Pune 5
Tianjin 5
Changsha 4
Chiyoda-ku 4
Dearborn 4
Florence 4
Mahé 4
Mülheim 4
Santa Clara 4
Washington 4
Abeokuta 3
Haikou 3
Hamamatsu 3
Hangzhou 3
Istanbul 3
San Venanzo 3
Verona 3
Zhengzhou 3
Bengaluru 2
Bologna 2
Chicago 2
Dhaka 2
Groningen 2
Kashan 2
Kunming 2
Mountain View 2
Ningbo 2
Norwalk 2
Redwood City 2
Riolo Terme 2
Toronto 2
Andover 1
Ardabil 1
Athens 1
Buk-gu 1
Cesenatico 1
Cislago 1
Davao City 1
Fremont 1
Gloucester 1
Grafing 1
Guangzhou 1
Hefei 1
Hunedoara 1
Hyderabad 1
Kawasaki 1
Kiev 1
Kuban 1
La Canada Flintridge 1
Lanzhou 1
Manila 1
Moscow 1
Muizenberg 1
Mumbai 1
North Bergen 1
North York 1
Totale 1.627
Salva come PNG Salva come JPEG
Nome #
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia 212
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 210
Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies 195
Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies 171
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 162
Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib 160
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment. 145
Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response 124
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia 123
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. 106
Philadelphia-positive patients who already harbour imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors. 105
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. 100
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. 99
Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia. 98
Low level mutations in the Bcr-Abl kinase domain may already be detected at diagnosis both in patients with Philadelphia-positive acute lymphoblastic leukemia and in patients with chronic phase chronic myeloid leukemia 89
null 85
null 77
null 57
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis 42
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome 37
Pancreatic enzymes elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure 27
Totale 2.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020501 0 15 10 43 70 61 70 69 69 38 15 41
2020/2021346 57 27 5 10 9 12 1 24 38 14 20 129
2021/2022444 51 6 34 46 36 28 9 44 12 29 78 71
2022/2023587 72 116 31 70 36 45 14 24 94 14 50 21
2023/2024211 5 21 5 18 12 90 23 15 2 3 12 5
2024/202530 13 17 0 0 0 0 0 0 0 0 0 0
Totale 2.424